English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Wednesday, June 25, 2025
康哲药业建议于新加坡交易所第二上市
17:24 HKT/SGT
从技术先驱到全球AMR第一 极智嘉商业化领跑行业
17:08 HKT/SGT
交易寶2025年5月亮相HOFEX 2025及HK Tech 300 Expo 助力商戶數碼轉型
13:58 HKT/SGT
MHI Receives Contract for Refurbishment of APM System at Singapore Changi Airport
13:00 HKT/SGT
LLVisionがソウルでAR翻訳メガネの新モデル「Leion Hey2」 を世界初披露:日常生活に革新をもたらすAI翻訳
13:00 HKT/SGT
交易宝2025年5月亮相HOFEX 2025及HK Tech 300 Expo 助力商户数码𨍭型
11:49 HKT/SGT
米アンソロピック、東京にAPAC地域初の拠点開設 日本企業からの需要増を受けて日本語版「クロード」提供へ
11:30 HKT/SGT
テクニカ・ゼンとBSI Professional Services Japan、日本企業のAIガバナンスのさらなる強化に向けて、新たに、AIリテラシー/ガバナンスの包括的な研修サービスの提供を開始
10:00 HKT/SGT
Special Summer Event "Tanabata Festival at Anime Tokyo Station" Feature a Public Recording of a Chat and Dramatic Reading by Voice Actors Miina Tominaga and Wataru Takagi on July 7
10:00 HKT/SGT
Technica Zen and BSI Professional Services Japan Launch Customizable Training to Strengthen AI Governance in Japanese Companies
09:00 HKT/SGT
PCG Showcases at HOFEX 2025 and HK Tech 300 Expo in May 2025, Driving Digital Transformation for Merchants
09:00 HKT/SGT
3rd ASEAN Procurement Innovation Summit & Awards 2025
08:23 HKT/SGT
Tuesday, June 24, 2025
The Executive Centre Further Expands in Tokyo with New Centres at JP Tower Level 11 and GranTokyo South Tower
22:00 HKT/SGT
Founders Metals Hits 22.5 m of 11.88 g/t Gold in New Discovery at Maria Geralda
19:39 HKT/SGT
35th HKTDC Hong Kong Book Fair opens on 16 July
19:03 HKT/SGT
超900倍認購創紀錄!海天味業港股上市創紀錄 開啟全球化新篇章
18:49 HKT/SGT
超900倍认购创纪录!海天味业港股上市创纪录 开启全球化新篇章
18:39 HKT/SGT
雲知聲港股招股:衝刺港股「AGI第一股」
14:35 HKT/SGT
云知声港股招股:冲刺港股AGI第一股
14:05 HKT/SGT
富士通、誰もが安心して暮らせる仮設住宅の実現に向けて、ミリ波レーダを活用した高齢者見守りの実証実験を実施
10:30 HKT/SGT
新冠疫情多地爆發 楷和醫療求診數量增
08:04 HKT/SGT
Two new microalgae genera discovered in Indonesian waters
07:00 HKT/SGT
Monday, June 23, 2025
ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology
21:00 HKT/SGT
Executive Appointments in Connection with the Establishment of NESIC Holdings
18:22 HKT/SGT
雲知聲在港招股 AGI獨角獸進入IPO衝刺階段
17:20 HKT/SGT
云知声在港招股 AGI独角兽进入IPO冲刺阶段
17:20 HKT/SGT
華領醫藥在2025ADA科學年會公佈多格列艾汀與DPP-4抑制劑聯用在恢復血糖穩態的同時有望降低血脂
15:09 HKT/SGT
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
12:05 HKT/SGT
YCP Releases New White Paper on the Shift to Affiliate Marketing in Southeast Asia
12:00 HKT/SGT
华领医药在2025ADA科学年会公布多格列艾汀与DPP-4抑制剂联用在恢复血糖稳态的同时有望降低血脂
11:11 HKT/SGT
YCP Releases New White Paper on the Shift to Affiliate Marketing in Southeast Asia
11:00 HKT/SGT
BW Digital and BW ESS launch BW Velora to drive greater digital sustainability
00:17 HKT/SGT
New method to blend functions for soft electronics
00:15 HKT/SGT
Saturday, June 21, 2025
U Power宣佈在香港投建55座智能換電站 香港首座示範運營智能換電站正式落成
20:22 HKT/SGT
U Power宣布在香港兴建55座智能换电站 香港首座示范营运智能换电站正式落成
18:32 HKT/SGT
「数字经济新引擎:以新质生产力推动数字文旅新产业」
17:09 HKT/SGT
康希諾重磅推出優佩欣疫苗 為兒童健康保駕護航的創新之選
12:09 HKT/SGT
「數字經濟新引擎:以新質生產力推動數字文旅新產業」
11:22 HKT/SGT
塑造全球增長新平台 - SPIEF-2025開放對話討論
09:48 HKT/SGT
塑造全球增长新平台 - SPIEF-2025开放对话讨论
09:34 HKT/SGT
Ditchit Detonates Iconic Twitter Bird to Symbolize Launch of Local Marketplace
06:00 HKT/SGT
Friday, June 20, 2025
Shaping a New Platform for Global Growth Discussed at Open Dialogue within SPIEF-2025
23:00 HKT/SGT
Shaping a New Platform for Global Growth Discussed at Open Dialogue within SPIEF-2025
23:00 HKT/SGT
Shaping a New Platform for Global Growth がSPIEF-2025のオープンダイアログで議論される
23:00 HKT/SGT
Global Economic Shifts in Focus as Madrid Professor Addresses SPIEF 2025 Opening Session
23:00 HKT/SGT
 ACN Search:
 
Abdullah Ayed Al Mazny, General Manager at Desert Dragon (ICS Arabia), and Ghufran Hamid, CEO of XDS, at the '10Mw Immersive Cooling for Ai Worlkload' Signing Ceremony on July 8, 2025.
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575